لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Preobrazhenskaya EV; N.N. Petrov Institute of Oncology, St. Petersburg, Russia.; St. Petersburg State Pediatric Medical University, St. Petersburg, Russia., Iyevleva AG; N.N. Petrov Institute of Oncology, St. Petersburg, Russia.; St. Petersburg State Pediatric Medical University, St. Petersburg, Russia., Suleymanova AM; The Dmitry Rogachev National Research Centre of Pediatric Hematology, Oncology and Immunology, Moscow, Russia., Tiurin VI; N.N. Petrov Institute of Oncology, St. Petersburg, Russia.; St. Petersburg State Pediatric Medical University, St. Petersburg, Russia., Mitiushkina NV; N.N. Petrov Institute of Oncology, St. Petersburg, Russia., Bizin IV; N.N. Petrov Institute of Oncology, St. Petersburg, Russia., Ivanstov AO; N.N. Petrov Institute of Oncology, St. Petersburg, Russia., Gorustovich OA; N.N. Petrov Institute of Oncology, St. Petersburg, Russia., Shelekhova KV; Clinical Research and Practical Center for Specialized Oncological Care, St. Petersburg, Russia., Kachanov DY; The Dmitry Rogachev National Research Centre of Pediatric Hematology, Oncology and Immunology, Moscow, Russia., Varfolomeeva SR; The Dmitry Rogachev National Research Centre of Pediatric Hematology, Oncology and Immunology, Moscow, Russia., Roschin VY; The Dmitry Rogachev National Research Centre of Pediatric Hematology, Oncology and Immunology, Moscow, Russia., Kazakova AN; The Dmitry Rogachev National Research Centre of Pediatric Hematology, Oncology and Immunology, Moscow, Russia., Litvinov DV; The Dmitry Rogachev National Research Centre of Pediatric Hematology, Oncology and Immunology, Moscow, Russia., Shamanskaya TV; The Dmitry Rogachev National Research Centre of Pediatric Hematology, Oncology and Immunology, Moscow, Russia., Savelov NA; Moscow City Oncology Hospital #62, Moscow, Russia., Suspitsin EN; N.N. Petrov Institute of Oncology, St. Petersburg, Russia.; St. Petersburg State Pediatric Medical University, St. Petersburg, Russia., Imyanitov EN; N.N. Petrov Institute of Oncology, St. Petersburg, Russia.; St. Petersburg State Pediatric Medical University, St. Petersburg, Russia.

المصدر: Pediatric blood & cancer [Pediatr Blood Cancer] 2020 May; Vol. 67 (5), pp. e28220. Date of Electronic Publication: 2020 Feb 16.

نوع المنشور: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-5017 (Electronic) Linking ISSN: 15455009 NLM ISO Abbreviation: Pediatr Blood Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Gene Expression Regulation, Neoplastic* , Gene Rearrangement* , Polymerase Chain Reaction*, Neoplasms/*genetics , Oncogene Proteins, Fusion/*genetics, Adolescent ; Child ; Child, Preschool ; Female ; Humans ; Infant ; Male

المؤلفون: Dyakonova YY; Dmitry Rogachev National Research Center for Pediatric Hematology, Oncology, and Immunology, Moscow, Russia., Bydanov OI; Dmitry Rogachev National Research Center for Pediatric Hematology, Oncology, and Immunology, Moscow, Russia.; Республиканский Republican Scientific and Practical Center for Pediatric Oncology, Hematology, and Immunology, Minsk, Republic of Belarus., Popov AM; Dmitry Rogachev National Research Center for Pediatric Hematology, Oncology, and Immunology, Moscow, Russia., Olshanskaya YV; Dmitry Rogachev National Research Center for Pediatric Hematology, Oncology, and Immunology, Moscow, Russia., Boichenko EG; СПбГУЗ «Children City Hospital №1, Saint-Petersburg, Russia., Aleynikova OV; Республиканский Republican Scientific and Practical Center for Pediatric Oncology, Hematology, and Immunology, Minsk, Republic of Belarus., Maschan MA; Dmitry Rogachev National Research Center for Pediatric Hematology, Oncology, and Immunology, Moscow, Russia., Shelikhova LN; Dmitry Rogachev National Research Center for Pediatric Hematology, Oncology, and Immunology, Moscow, Russia., Litvinov DV; Dmitry Rogachev National Research Center for Pediatric Hematology, Oncology, and Immunology, Moscow, Russia., Khachatryan LA; Dmitry Rogachev National Research Center for Pediatric Hematology, Oncology, and Immunology, Moscow, Russia., Ponomareva NI; Russian Children Clinical Hospital, Moscow, Russia., Fechina LG; Regional Children Clinical Hospital №1, Ekaterinburg, Russia., Novichkova GA; Dmitry Rogachev National Research Center for Pediatric Hematology, Oncology, and Immunology, Moscow, Russia., Pashanov ED; Dmitry Rogachev National Research Center for Pediatric Hematology, Oncology, and Immunology, Moscow, Russia., Karachunskiy AI; Dmitry Rogachev National Research Center for Pediatric Hematology, Oncology, and Immunology, Moscow, Russia.

المصدر: Terapevticheskii arkhiv [Ter Arkh] 2018 Aug 17; Vol. 90 (7), pp. 38-50.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: ZAO 'Konsilium Medikum Country of Publication: Russia (Federation) NLM ID: 2984818R Publication Model: Print Cited Medium: Print ISSN: 0040-3660 (Print) Linking ISSN: 00403660 NLM ISO Abbreviation: Ter Arkh Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Arabinonucleosides/*therapeutic use , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/*drug therapy , Prodrugs/*therapeutic use, Antineoplastic Agents/adverse effects ; Antineoplastic Agents/pharmacokinetics ; Arabinonucleosides/adverse effects ; Arabinonucleosides/pharmacokinetics ; Clinical Trials as Topic ; Humans ; Injections, Intravenous ; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/mortality ; Prodrugs/adverse effects ; Prodrugs/pharmacokinetics ; Progression-Free Survival ; Recurrence

المؤلفون: Karachunsky AI; D. Rogachev Federal Research Clinical Center of Pediatric Hematology, Oncology, and Immunology, Moscow, Russia; N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow, Russia., Rumyantseva YV; D. Rogachev Federal Research Clinical Center of Pediatric Hematology, Oncology, and Immunology, Moscow, Russia; N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow, Russia., Lagoiko SN; D. Rogachev Federal Research Clinical Center of Pediatric Hematology, Oncology, and Immunology, Moscow, Russia., Bührer C; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Germany., Tallen G; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Germany., Aleinikova OV; Republican Research and Practical Center for Pediatric Oncology and Hematology, Minsk, Belarus., Bydanov OI; D. Rogachev Federal Research Clinical Center of Pediatric Hematology, Oncology, and Immunology, Moscow, Russia; Republican Research and Practical Center for Pediatric Oncology and Hematology, Minsk, Belarus., Korepanova NV; D. Rogachev Federal Research Clinical Center of Pediatric Hematology, Oncology, and Immunology, Moscow, Russia., Baidun LV; Russian Children's Clinical Hospital, Ministry of Health of Russia, Moscow, Russia., Nasedkina TV; D. Rogachev Federal Research Clinical Center of Pediatric Hematology, Oncology, and Immunology, Moscow, Russia., Stackelberg AV; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Germany., Novichkova GA; D. Rogachev Federal Research Clinical Center of Pediatric Hematology, Oncology, and Immunology, Moscow, Russia; N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow, Russia., Maschan AA; D. Rogachev Federal Research Clinical Center of Pediatric Hematology, Oncology, and Immunology, Moscow, Russia; N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow, Russia., Litvinov DV; D. Rogachev Federal Research Clinical Center of Pediatric Hematology, Oncology, and Immunology, Moscow, Russia; N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow, Russia., Ponomareva NI; Russian Children's Clinical Hospital, Ministry of Health of Russia, Moscow, Russia., Kondratchik KL; N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow, Russia; Morozov City Children's Clinical Hospital, Moscow Healthcare Department, Moscow, Russia., Mansurova EG; N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow, Russia., Fechina LG; Regional Children's Clinical Hospital One, Yekaterinburg, Russia., Streneva OV; Regional Children's Clinical Hospital One, Yekaterinburg, Russia., Yudina NB; Voronezh Regional Children's Clinical Hospital One, Voronezh, Russia., Sharapova GR; Nizhnevartovsk District Children's Clinical Hospital, Nizhnevartovsk, Khanty-Mansi Autonomic District-Yugra, Russia., Shamardina AV; Nizhny Novgorod Regional Children's Clinical Hospital, Nizhny Novgorod, Russia., Gerbek IE; Tomsk Regional Clinical Hospital, Tomsk, Russia., Shapochnik AP; Orenburg Regional Clinical Oncology Dispensary, Orenburg, Russia., Rumyantsev AG; D. Rogachev Federal Research Clinical Center of Pediatric Hematology, Oncology, and Immunology, Moscow, Russia., Henze G; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Germany.

المصدر: Terapevticheskii arkhiv [Ter Arkh] 2015; Vol. 87 (7), pp. 41-50.

نوع المنشور: English Abstract; Journal Article; Multicenter Study; Randomized Controlled Trial

بيانات الدورية: Publisher: ZAO 'Konsilium Medikum Country of Publication: Russia (Federation) NLM ID: 2984818R Publication Model: Print Cited Medium: Print ISSN: 0040-3660 (Print) Linking ISSN: 00403660 NLM ISO Abbreviation: Ter Arkh Subsets: MEDLINE

مواضيع طبية MeSH: Dexamethasone/*therapeutic use , Methylprednisolone/*therapeutic use , Precursor Cell Lymphoblastic Leukemia-Lymphoma/*drug therapy, Adolescent ; Age Distribution ; Age Factors ; Child ; Child, Preschool ; Female ; Glucocorticoids/therapeutic use ; Humans ; Incidence ; Infant ; Male ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/epidemiology ; Prospective Studies ; Republic of Belarus/epidemiology ; Russia/epidemiology ; Survival Rate/trends ; Treatment Outcome ; Young Adult

المؤلفون: Rumiantseva IuV, Karachunskiĭ AI, Aleĭnikova OV, Fechina LG, Shamardina AV, Litvinov DV, Ponomareva NI, Boĭchenko EG, Dudkin SA, Streneva OV, Kondratchik KL, Mansurova EG, Minkina LM, Lapotentova ES, Iniushkina EV, Iudina NB, Pavlova GP, Zhukovskaia EV, Khlebnikova OP, Lagoĭko SN, Basharova EV, Denisov RE, Zlobina VD, Banshchikova ES, Aslanian KS, Kondakova EV, Tselousova EV, Miakova NV, Turobova TV, Ryskal' OV, Chipsanova NF, Varfolomeeva SR, Rumiantsev AG

المصدر: Terapevticheskii arkhiv [Ter Arkh] 2010; Vol. 82 (7), pp. 11-9.

نوع المنشور: Clinical Trial; English Abstract; Journal Article; Multicenter Study

بيانات الدورية: Publisher: ZAO 'Konsilium Medikum Country of Publication: Russia (Federation) NLM ID: 2984818R Publication Model: Print Cited Medium: Print ISSN: 0040-3660 (Print) Linking ISSN: 00403660 NLM ISO Abbreviation: Ter Arkh Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Precursor Cell Lymphoblastic Leukemia-Lymphoma/*drug therapy, Adolescent ; Age Factors ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Child ; Child, Preschool ; Disease-Free Survival ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Female ; Humans ; Infant ; Male ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/mortality ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/prevention & control ; Recurrence ; Russia